Olvi (OLVAS) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
16 Apr, 2026Executive summary
Maintained or increased market shares in key categories despite weak consumer demand, low confidence, and challenging weather, especially in the Baltics and Belarus.
Continued strategic investments in brands, operations, analytics, and acquisitions to support long-term growth and competitiveness.
Completed three acquisitions in Latvia, Estonia, and Bosnia and Herzegovina, expanding market reach and non-alcoholic offerings.
Financial highlights
Q3 2025 net sales rose 0.7% year-over-year to EUR 186.2 million; 9M net sales up 0.8% to EUR 514.1 million.
Q3 EBIT fell 9.8% to EUR 27.0 million; 9M EBIT down 8.8% to EUR 65.7 million.
Gross margin improved to 43.0% in Q3 and 41.7% for 9M, reflecting better profitability.
Earnings per share for 9M was EUR 2.27, down from EUR 2.62 year-over-year.
Investments totaled EUR 37.0 million for 9M, up from EUR 27.0 million year-over-year.
Outlook and guidance
2025 operating result guidance revised to EUR 80–84 million (previously EUR 82–86 million) due to weak summer demand and ongoing uncertainty.
Q4 is expected to be better than the previous year, supported by cost controls and non-repeating prior year expenses.
Profitability in Latvia and Lithuania is expected to recover, with improvements seen in September.
Latest events from Olvi
- Profitability rose 8.8% in H1 2024, with stable sales and EBIT guidance at €74–80 million.OLVAS
Q2 202416 Apr 2026 - Profitability and cash flow surged, with 2024 guidance raised amid persistent market risks.OLVAS
Q3 202416 Apr 2026 - Ninth year of growth, higher margins, €1.30 dividend, and €82–90M profit guidance for 2025.OLVAS
Q4 202416 Apr 2026 - Adjusted EBIT up 10.9% year-over-year, with 2025 profit guidance unchanged at EUR 82–90 million.OLVAS
Q1 202516 Apr 2026 - Stable net sales and strong market shares offset by lower volumes and reduced profitability.OLVAS
Q2 202516 Apr 2026 - 2025 saw higher sales, profit, and acquisitions, with strong Q4 and positive 2026 outlook.OLVAS
Q4 202513 Apr 2026